CTOs on the Move

Cambridge Biomedical

www.cambridgebiomedical.com

 
Cambridge Biomedical Inc. is a specialized CRO serving the diverse requirements of the CRO and Biopharmaceutical/Pharmaceutical and Diagnostic markets, utilizing its multi-platform laboratory science capabilities and state of the art systems and procedures. We provide our clients with assay development, assay validation and testing services in support of their clinical trial and pharmaceutical development objectives. Our breadth of experience in laboratory science uniquely positions Cambridge Biomedical to serve as trusted advisor to our clients and provide value-added services beyond the requirements of the project. We are committed to developing each service engagement into a long term relationship.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Natrix Separations

Natrix Separations is a leading supplier of high performance, single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets.   Natrix Separations’ patented Advective chromatography technology combines the high binding capacity, selectivity and specificity associated with conventional resin-based chromatography with the high throughput and ease-of-use of traditional membrane products.   The product consists of a polymeric hydrogel formed within a flexible porous support matrix. The support matrix provides mechanical strength, while the hydrogel properties determine the separation chemistry of the product. The Natrix Chromatography technology now enables single use for primary capture through final polish.

Accutrace Testing Inc

Accutrace Testing Inc is a Arlington, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeoGenomics

NeoGenomics Laboratories is a specialized genetics laboratory providing the latest diagnostic testing technologies to the pathology and oncology markets.

Bell Laboratories Inc.

Bell Laboratories Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

NovaSom

NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructive sleep apnea (OSA). As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use for the diagnosis of sleep apnea, with clinically proven equivalence * to conventional polysomnography (PSG). NovaSom works with physicians, private insurers, government and public health organizations to address concerns about the large numbers of individuals with undiagnosed sleep apnea. It is our shared concern that millions of Americans are utilizing more health care resources and incurring greater health care costs because their OSA has not been properly diagnosed or treated. It is also our belief that early diagnosis and treatment of OSA can improve lives and help hold down health care costs. Our mission is to improve the health care and quality of life of those impacted by sleep disorders through innovative diagnostic services and by promoting adherence to prescribed therapies.